Endogenous and Exogenous Electrophilic Modifications Reshape Antigen Presentation and Recognition

This study demonstrates that both endogenous and exogenous electrophiles can induce irreversible, non-enzymatic post-translational modifications on antigenic peptides, which reshape the immunopeptidome by altering MHC-I stability and disrupting T cell recognition even when peptide binding is preserved.

The Gist

The Big Picture: The Immune System's "Wanted" Posters

Imagine your body is a bustling city, and your immune system is the police force. To catch bad guys (like viruses or cancer cells), the police need to see "Wanted" posters displayed on the walls of every building.

In your body, these posters are MHC-I molecules. They hold up tiny snippets of proteins (peptides) from inside the cell. If the snippet looks normal, the police ignore it. If the snippet looks like a criminal (a virus or a mutation), the police (T cells) attack the building.

The Problem: Usually, we think these "Wanted" posters only change if the criminal's DNA changes (a mutation). But this paper argues that chemicals can change the posters too, even if the DNA stays the same.

---

The Analogy: The "Graffiti" on the Poster

The researchers discovered that chemicals—both those made naturally inside your body and those from the outside world (like pesticides or food)—can act like spray paint or graffiti.

1. The Graffiti (Chemical Modifications): These chemicals stick to the "Wanted" poster (the peptide) and change its appearance.
2. The Irreversible Mark: Unlike a sticker you can peel off, this "graffiti" is permanent. Once it's there, it stays.
3. The Confusion:
   • Sometimes the graffiti makes the poster look so weird that the police can't read it at all, and they stop looking for the criminal (the cell escapes detection).
   • Sometimes the graffiti makes a normal person look like a criminal, causing the police to attack innocent cells (autoimmune disease).

The Three Key Findings

1. The "Graffiti" Changes the Message

The team tested a specific "Wanted" poster (a peptide called SIINFEKL). They added different types of chemical "graffiti" to it.

• Result: Even though the police station (the MHC molecule) could still hold the poster up, the police officers (T cells) couldn't recognize it anymore.
• The Lesson: You don't need to change the DNA to change the immune system's reaction. Just changing the chemical "makeup" of the protein is enough to confuse the immune system.

2. Catching the Invisible Graffiti

Detecting these chemical changes is hard because they are rare and messy, like trying to find one specific drop of blue paint in a bucket of mixed colors.

• The Solution: The scientists invented a special "magnet" (a chemical probe). This magnet only sticks to the specific type of graffiti they were looking for.
• The Result: They used this magnet to pull out modified peptides from cancer cells and found that these chemical changes are actually happening in real tumors. This gives scientists a new way to hunt for hidden cancer targets.

3. The "Good" vs. "Bad" Paint

The researchers tested chemicals from two very different sources:

• The "Bad" Paint: Environmental toxins like pesticides (e.g., chlorothalonil).
• The "Good" Paint: Healthy foods like broccoli and Brussels sprouts, which contain compounds called Isothiocyanates (ITCs).

The Surprise: Both the "bad" pesticides and the "good" broccoli chemicals acted like graffiti. They both stuck to the peptides and stopped the T cells from recognizing the target.

• Why does this matter?
  • Pesticides: They might be tricking the immune system, making it ignore cancer cells or attack healthy ones.
  • Broccoli (ITCs): This is fascinating. Maybe eating broccoli "trains" the immune system to recognize the modified version of a protein. If you stop eating broccoli, your immune system might suddenly see the unmodified protein as a stranger and get confused. It suggests that our diet might be silently training our immune system's "Wanted" list.

The "Surface" Twist

One of the coolest parts of the study is that they proved these chemicals can paint the poster after it's already up on the wall.

• Imagine a police officer walking by a poster. A chemical spray hits the poster right then and there, changing the face on the poster instantly. The officer stops and says, "Wait, that's not the guy I was looking for!"
• This means you don't need to be sick inside to have your immune system confused; a chemical exposure on the surface of your cells is enough to change the message.

The Takeaway

This paper changes how we view "self" vs. "non-self."

• Old View: Your immune system only cares about your DNA.
• New View: Your immune system also cares about the chemical environment. What you eat, what chemicals you breathe, and what your body produces internally can permanently alter the "Wanted" posters on your cells.

This could explain why some people develop autoimmune diseases, why some cancers hide from treatment, and how our diet might be secretly shaping our immune defense. The "graffiti" on our cells matters just as much as the blueprint inside them.

Technical Summary

1. Problem Statement

The adaptive immune system relies on Major Histocompatibility Complex class I (MHC-I) molecules to present peptide antigens to cytotoxic T lymphocytes (CTLs). While T cell recognition is traditionally defined by peptide sequence, this study addresses a critical gap: the impact of non-enzymatic post-translational modifications (PTMs) driven by reactive electrophiles.

• The Gap: Unlike enzymatic PTMs (e.g., phosphorylation), which are reversible and regulated, non-enzymatic modifications driven by endogenous metabolites (e.g., reactive oxygen species, methylglyoxal) and exogenous chemicals (e.g., pesticides, pharmaceuticals, dietary isothiocyanates) are largely irreversible.
• The Hypothesis: These stable chemical modifications can alter the structure of peptide antigens presented on MHC-I, potentially creating "neoantigens" that escape central tolerance (thymic selection) and disrupt T cell recognition, even if MHC binding affinity is preserved.
• The Challenge: Detecting these modifications is difficult due to their low stoichiometric abundance, structural diversity, and the lack of specific enrichment tools to isolate them from the complex immunopeptidome.

2. Methodology

The authors employed a multi-pronged approach combining synthetic chemistry, immunology, and chemical proteomics:

• Synthetic Peptide Models:

  • Used the model epitope SIINFEKL (OVA) and cancer-associated peptides.
  • Synthesized variants with specific non-enzymatic PTMs: lysine oxidation (formyl, aminoadipic, homocitrulline), lysine lactylation, asparagine deamidation (aspartate/isoaspartate), cysteine sulfonation, and methionine oxidation.
  • Synthesized peptides modified by exogenous electrophiles: chlorothalonil (fungicide), acetylsalicylic acid (aspirin), and isothiocyanates (PEITC, AITC, SFN).

• Functional Assays:

  • RMA-S Stabilization Assay: Used TAP-deficient RMA-S cells to measure peptide-MHC-I binding affinity. Surface H-2Kb expression levels were quantified via flow cytometry to determine pMHC stability.
  • B3Z T Cell Activation Assay: Co-cultured RMA-S cells (loaded with peptides) or B16-OVA melanoma cells (expressing full-length OVA) with B3Z reporter T cells (specific for SIINFEKL). T cell activation was measured via $\beta$-galactosidase activity.
  • Surface Modification Assay: Pre-loaded RMA-S cells with unmodified SIINFEKL, washed away free peptide, and treated with electrophiles to test if surface-bound pMHC complexes could be directly modified and lose T cell recognition.

• Chemical Enrichment Strategy:

  • Developed a probe-based workflow to capture non-enzymatically acylated peptides.
  • Used a thioester-based alkyne probe (Probe 1) to label acylation sites on cellular proteins.
  • Performed immunoaffinity purification of MHC-I peptides, followed by bioorthogonal conjugation to a biotin linker and streptavidin enrichment.
  • Analyzed enriched peptides via LC-MS/MS.

• Proteome-Wide Reactivity Screening:

  • Used competitive activity-based protein profiling (ABPP) with gel-based and flow cytometry assays to screen environmental chemicals (herbicides, pesticides) and pharmaceuticals for their ability to modify cysteine and lysine residues in the proteome.

3. Key Contributions

1. Systematic Mapping of Non-Enzymatic PTMs: The study comprehensively evaluated how specific chemical modifications (oxidation, deamidation, acylation) affect pMHC-I stability and TCR engagement.
2. Development of an Enrichment Platform: Created the first chemical enrichment strategy specifically designed to isolate and identify non-enzymatically modified peptides directly from the MHC-I immunopeptidome.
3. Demonstration of "Chemical Neoantigens": Provided evidence that exogenous environmental chemicals and dietary metabolites can covalently modify antigenic peptides, rendering them invisible to T cells despite preserved MHC binding.
4. Surface Modification Mechanism: Proved that electrophiles can directly modify peptides already bound to MHC-I on the cell surface, independent of intracellular antigen processing.

4. Key Results

• Impact on pMHC Stability and TCR Recognition:

  • Lysine Modifications: Modifications at solvent-exposed lysine residues (e.g., K7 in SIINFEKL) generally did not disrupt MHC-I binding but abolished T cell activation. This suggests TCRs are highly sensitive to charge and steric changes at TCR-contact residues.
  • Backbone Modifications: Deamidation of asparagine (N4) and oxidation of cysteine significantly reduced pMHC stability, leading to poor surface display.
  • Cancer Peptides: Non-enzymatic modifications (methionine oxidation, deamidation) on cancer-associated peptides drastically reduced H-2Kb binding, suggesting a potential mechanism for immune evasion in tumors.

• Chemical Enrichment Success:

  • The alkyne-tagged probe successfully enriched two MHC-I-associated peptides (RKSPRPAGP and EKNKQNKTKL) from MDA-MB-231 cells. Both originated from nuclear DNA repair proteins, suggesting these proteins are frequent targets of non-enzymatic acylation and presentation.

• Exogenous Electrophiles (Environmental & Dietary):

  • Reactivity Screening: Chlorothalonil (a fungicide) and PEITC/AITC (dietary isothiocyanates) showed the highest proteome-wide reactivity toward cysteine and lysine residues.
  • Loss of T Cell Activation: Peptides modified by chlorothalonil, aspirin, PEITC, or AITC retained MHC-I binding but completely failed to activate T cells.
  • Direct Surface Modification: Treatment of pre-loaded RMA-S cells with chlorothalonil, PEITC, or AITC reduced T cell activation to background levels. This confirms that electrophiles can directly alter the "self" antigen on the cell surface, creating a "non-self" signal that T cells fail to recognize (or potentially recognize as altered self, leading to tolerance issues).
  • Specificity Matters: Sulforaphane (SFN), another ITC, showed weaker reactivity and did not disrupt T cell recognition, highlighting that not all electrophiles have the same immunological impact.

5. Significance and Implications

• Redefining "Non-Self": The study expands the definition of neoantigens beyond genetic mutations to include chemically modified epitopes. These modifications can occur due to metabolic stress (endogenous) or environmental exposure (exogenous).
• Mechanism for Autoimmunity and Immune Evasion:
  • Autoimmunity: Irreversible modifications occurring after thymic involution (aging) may generate neoantigens that T cells have not been tolerized against, potentially triggering autoimmune responses.
  • Cancer Immune Evasion: Modifications that destabilize pMHC complexes could allow tumor cells to hide immunogenic epitopes from CTLs.
• Environmental Health: The findings suggest that exposure to common pesticides and drugs can fundamentally alter the immunopeptidome, potentially contributing to chronic inflammation or altering responses to vaccines and immunotherapies.
• Dietary Paradox: The paper proposes a novel hypothesis regarding dietary isothiocyanates (ITCs). While often considered "beneficial," they may act as "protective" electrophiles that shape immune tolerance during thymic education. Conversely, their absence might leave residues vulnerable to "harmful" environmental electrophiles, creating an antigenic mismatch.
• Methodological Advance: The chemical enrichment strategy provides a critical tool for the field to move beyond theoretical predictions and physically identify these elusive, modified peptides in clinical and biological samples.

In conclusion, this work establishes that chemical identity is as critical as sequence identity in antigen presentation. Non-enzymatic electrophilic modifications act as a dynamic layer of regulation (and dysregulation) in the immune system, bridging the gap between environmental exposure, metabolic state, and adaptive immunity.